These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7914291)

  • 1. Specific vaccine therapy in chronic hepatitis B infection.
    Pol S; Driss F; Michel ML; Nalpas B; Berthelot P; Brechot C
    Lancet; 1994 Jul; 344(8918):342. PubMed ID: 7914291
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous steroids/interferon therapy in chronic hepatitis B.
    Causse X; Godinot H; Chevallier M; Chossegros P; Zoulim F; Zarski JP; Meschiewitz C; Albrecht J; Trépo C
    J Hepatol; 1993 Jan; 17(1):128-9. PubMed ID: 8445212
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon in clinically stable, replicative chronic hepatitis B: good news for some.
    Koff RS
    Gastroenterology; 1991 Jan; 100(1):277-9. PubMed ID: 1983834
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent hepatitis B virus following interferon alfa therapy and liver transplantation.
    Lavine JE; Lake JR; Ascher NL; Ferrell LD; Ganem D; Wright TL
    Gastroenterology; 1991 Jan; 100(1):263-7. PubMed ID: 1983831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with hepatitis B vaccine and interferon alfa in chronic hepatitis B.
    Kaymakoğlu S; Demir K; Cakaloğlu Y; Tuncer I; Dinçer D; Gürel S; Okten A
    Am J Gastroenterol; 1999 Mar; 94(3):856-7. PubMed ID: 10086686
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferon for hepatitis B: US experience.
    Perrillo RP
    Gut; 1993; 34(2 Suppl):S95-6. PubMed ID: 8314498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic viral hepatitis--benefits of current therapies.
    Hoofnagle JH; Lau D
    N Engl J Med; 1996 May; 334(22):1470-1. PubMed ID: 8618588
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous interferon-beta in chronic hepatitis B: promises.
    Koff RS
    Am J Gastroenterol; 1993 Feb; 88(2):171-3. PubMed ID: 8424416
    [No Abstract]   [Full Text] [Related]  

  • 9. Pilot interferon-beta trial in children with chronic hepatitis B who had previously not responded to interferon-alpha therapy.
    Ruíz-Moreno M; Fernández P; Leal A; Bartolomé J; Castillo I; Oliva H; Carreño V
    Pediatrics; 1997 Feb; 99(2):222-5. PubMed ID: 9024450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alfa-2b for chronic hepatitis B.
    Herzenberg H
    N Engl J Med; 1991 Feb; 324(7):493-4. PubMed ID: 2025320
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus replication patterns after orthotopic liver transplantation: de novo versus recurrent infection.
    Douglas DD; Rakela J; Taswell HF; Krom RA; Wiesner RH
    Transplant Proc; 1993 Apr; 25(2):1755-7. PubMed ID: 8470154
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B.
    Rumi M; Romeo R; De Filippi F; Marcelli R; Del Ninno E; van Eyken P; Desmet V; Colombo M
    Ital J Gastroenterol; 1993 Apr; 25(3):117-20. PubMed ID: 8507888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alfa-2b for decompensated liver disease caused by either chronic hepatitis B or C: preliminary results of a pilot study.
    Dimopoulou M; Fafoutis K; Basiliou K; Ketikoglou J; Karvountzis G
    Gut; 1993; 34(2 Suppl):S104-5. PubMed ID: 8314470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different treatment combinations for chronic hepatitis B infection.
    Demirtürk N; Usluer G; Ozgünes I; Colak H; Kartal ED; Dinçer S
    J Chemother; 2002 Jun; 14(3):285-9. PubMed ID: 12120884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
    Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon treatment of chronic active hepatitis B: effect of a six month treatment regimen.
    Raptopoulou M; Orphanou H; Vrettou H; Akribiadis E; Chadzikonstantinou L; Goulis G
    Gut; 1993; 34(2 Suppl):S102-3. PubMed ID: 8314469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine.
    Marcellin P; Boyer N; Colin JF; Martinot-Peignoux M; Lefort V; Matheron S; Erlinger S; Benhamou JP
    Gut; 1993; 34(2 Suppl):S106. PubMed ID: 8314471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients.
    Villa E; Grottola A; Trande P; Seium Y; Rebecchi AM; Dugani A; Manenti F
    Lancet; 1993 May; 341(8857):1413. PubMed ID: 7684479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.